Your browser doesn't support javascript.
loading
Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.
Aguirre, T A S; Teijeiro-Osorio, D; Rosa, M; Coulter, I S; Alonso, M J; Brayden, D J.
Affiliation
  • Aguirre TA; Centro de Ciências Exatas e Tecnologia, Universidade de Caxias do Sul (UCS), Caxias do Sul, Brazil.
  • Teijeiro-Osorio D; CIMUS Research Institute, University of Santiago de Compostela, Santiago de Compostela, Spain.
  • Rosa M; Sigmoid Pharma, Dublin City University, Invent Centre, Dublin 9, Ireland.
  • Coulter IS; Sigmoid Pharma, Dublin City University, Invent Centre, Dublin 9, Ireland.
  • Alonso MJ; CIMUS Research Institute, University of Santiago de Compostela, Santiago de Compostela, Spain. Electronic address: mariaj.alonso@usc.es.
  • Brayden DJ; UCD School of Veterinary Medicine and UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. Electronic address: david.brayden@ucd.ie.
Adv Drug Deliv Rev ; 106(Pt B): 223-241, 2016 11 15.
Article in En | MEDLINE | ID: mdl-26921819
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Drug Delivery Systems / Intestinal Absorption Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Brazil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Drug Delivery Systems / Intestinal Absorption Limits: Animals / Humans Language: En Journal: Adv Drug Deliv Rev Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: Brazil